Vaccination

NEW YORK — As vaccination coverage declines globally, pediatricians need to prepare to encounter more measles cases in their communities, according to a presentation at the Infectious Diseases in Children Symposium.

NEW YORK — The 37th annual Infectious Diseases in Children Symposium will address the possibility that measles and chickenpox may make a comeback due to waning vaccine coverage.

NEW YORK — In this video at the Infectious Diseases in Children Symposium, Catherine Mary Healy, MBBCh, describes what she called “an exciting time” for meningococcal vaccines.

Measles cases increased globally by 20% in 2023, and roughly 22 million children missed their first measles vaccine dose, according to the CDC and WHO’s annual global measles report.

More than half of children with acute otitis media and 32% of children with upper respiratory infections tested positive for multiple pathogens in their nasal passages, according to a study presented at IDWeek.

A CDC advisory committee on Thursday voted unanimously to “harmonize” serogroup B meningococcal vaccine recommendations for healthy adolescents and young adults and children who have a higher risk for infection.

A CDC advisory committee on Wednesday recommended that adults aged 65 years or older and anyone who is at least moderately immunocompromised receive a second dose of COVID-19 vaccine this season.

Another monoclonal antibody for preventing respiratory syncytial virus disease in infants could enter the market as early as next year, based on the results of two studies presented at IDWeek, Merck said.

LOS ANGELES — Interim data from a phase 2 clinical trial of the Jynneos mpox vaccine showed that it is safe and generates an antibody response in adolescents that is similar to the response seen in adults, researchers reported.